Elias Jabbour, M.D.
M.D. Anderson Cancer Center
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Suning Chen, M.D., Ph.D.
First Affiliated Hospital of Suzhou Medical College
Shared therapeutic areas:
Worked with same sponsors:
Weili Zhao, M.D., Ph.D.
Shanghai Jiaotong University School of Medicine Ruijin Hospital
Shared therapeutic areas:
Worked with same sponsors:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
K A Bradstock), Dr.
Westmead Hospital
Shared therapeutic areas:
J Szer, Dr.
Royal Melbourne Hospital, Parkville, Australia
Shared therapeutic areas:
E Gluckman, Dr.
Hopital St Louis, Paris, France
Shared therapeutic areas:
J Rowe, Dr.
Rambam Medical Center, Haifa, Israel
Shared therapeutic areas:
G Lambertenghi-Deliliers, Dr.
Padiglione G Marcora, Ospedale Maggiore di Milano, Italy
Shared therapeutic areas:
T Ruutu, Dr.
Helsinki University CT. Rentral Hospital, Finland
Shared therapeutic areas:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of Olverembatinib (HQP1351) in Patients With CML-CP
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
All 2 trials loaded